Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs. Listen to podcast below:
Read the transcript, which includes charts, below.
Read more »Original Article
You may also like
Farewell Pharma Friends! Beware of the...
Farewell Pharma Friends! Beware of the...
Why Has There Been a Drop in FDA Enforcement Activity?
Why Has There Been a Drop in FDA Enforcement Activity?
Dancing with Fentanyl: Insys Sales Reps Caught Rapping...
Dancing with Fentanyl: Insys Sales Reps Caught Rapping...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.